Effects of Myofacial Release Technique and Sciatic Nerve Slider Technique in Sciatica
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Jul 31, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of two treatment techniques—myofascial release and the sciatic nerve slider technique—on people suffering from sciatica, which is pain that travels down the back of the leg due to problems with the sciatic nerve. The trial is specifically looking at how these treatments can help reduce pain, improve movement, and decrease disability among male cricket players aged 18 to 35 who have been diagnosed with sciatica and have experienced lower back pain for at least three months.
If you or someone you know is a male cricketer in that age group and has been dealing with sciatica, you may be eligible to participate. Participants will receive treatments to help relieve their pain and improve their physical function. It's important to note that those with certain medical histories, like systemic diseases, trauma, or previous surgeries, may not qualify for the study. This trial is significant because it aims to provide new insights into effective and cost-efficient ways to manage sciatic pain, potentially reducing the number of visits needed for treatment.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Age group between 18-35 yrs.
- • Male cricketers
- • Pre diagnosed Patients suffering from sciatica referred from Orthopedic.
- • History of low back pain atleast 03 months before enrollement.
- • Pain while examing when straight leg test (SLR) is performed.
- • Patients who are willing to particiapate in the study
- Exclusion Criteria:
- • History of any systemic disease
- • History of trauma
- • History of previous fracture in lower limb.
- • History of prior Surgery
- • Corticosteroid injection for lumber radiculopathy within previous 03 momths;
- • Any known malignancy /neoplasma involved side.
- • Diagnosed/known psychiatric illness.
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lahore, Punjab, Pakistan
Patients applied
Trial Officials
Muhammad Mohsin Raza
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported